nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP3A4—bone cancer	0.521	1	CbGaD
Theophylline—CYP1B1—Doxorubicin—bone cancer	0.0742	0.416	CbGbCtD
Theophylline—SLC22A7—Methotrexate—bone cancer	0.0651	0.364	CbGbCtD
Theophylline—CYP2C9—Cisplatin—bone cancer	0.0196	0.11	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—bone cancer	0.012	0.0672	CbGbCtD
Theophylline—Venous thrombosis—Carboplatin—bone cancer	0.00991	0.0771	CcSEcCtD
Theophylline—Fluid overload—Carboplatin—bone cancer	0.0086	0.0669	CcSEcCtD
Theophylline—CYP3A4—Doxorubicin—bone cancer	0.00763	0.0427	CbGbCtD
Theophylline—Extravasation—Carboplatin—bone cancer	0.00613	0.0477	CcSEcCtD
Theophylline—Diuresis—Cisplatin—bone cancer	0.00506	0.0394	CcSEcCtD
Theophylline—Phlebitis—Carboplatin—bone cancer	0.00451	0.035	CcSEcCtD
Theophylline—Venous thrombosis—Cisplatin—bone cancer	0.00291	0.0226	CcSEcCtD
Theophylline—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.0027	0.021	CcSEcCtD
Theophylline—Aminophylline—CYP3A4—bone cancer	0.00254	0.746	CrCbGaD
Theophylline—Fluid overload—Cisplatin—bone cancer	0.00252	0.0196	CcSEcCtD
Theophylline—Sinus tachycardia—Epirubicin—bone cancer	0.002	0.0156	CcSEcCtD
Theophylline—Infection—Carboplatin—bone cancer	0.0019	0.0147	CcSEcCtD
Theophylline—Sinus tachycardia—Doxorubicin—bone cancer	0.00185	0.0144	CcSEcCtD
Theophylline—Extravasation—Cisplatin—bone cancer	0.0018	0.014	CcSEcCtD
Theophylline—Hyperuricaemia—Cisplatin—bone cancer	0.00169	0.0132	CcSEcCtD
Theophylline—Blood uric acid increased—Cisplatin—bone cancer	0.0016	0.0124	CcSEcCtD
Theophylline—Body temperature increased—Carboplatin—bone cancer	0.00151	0.0117	CcSEcCtD
Theophylline—Venous thrombosis—Epirubicin—bone cancer	0.00149	0.0116	CcSEcCtD
Theophylline—Venous thrombosis—Doxorubicin—bone cancer	0.00138	0.0107	CcSEcCtD
Theophylline—Phlebitis—Cisplatin—bone cancer	0.00132	0.0103	CcSEcCtD
Theophylline—Polyuria—Cisplatin—bone cancer	0.0013	0.0101	CcSEcCtD
Theophylline—Haematemesis—Methotrexate—bone cancer	0.00124	0.00964	CcSEcCtD
Theophylline—Anaphylactoid reaction—Cisplatin—bone cancer	0.00118	0.00915	CcSEcCtD
Theophylline—Haematemesis—Epirubicin—bone cancer	0.00116	0.00902	CcSEcCtD
Theophylline—Hypercalcaemia—Epirubicin—bone cancer	0.00116	0.00902	CcSEcCtD
Theophylline—Ventricular arrhythmia—Epirubicin—bone cancer	0.00109	0.00846	CcSEcCtD
Theophylline—Irritability—Cisplatin—bone cancer	0.00109	0.00845	CcSEcCtD
Theophylline—Albuminuria—Epirubicin—bone cancer	0.00108	0.00839	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—bone cancer	0.00107	0.00834	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—bone cancer	0.00107	0.00834	CcSEcCtD
Theophylline—Hypokalaemia—Cisplatin—bone cancer	0.00104	0.00806	CcSEcCtD
Theophylline—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00101	0.00783	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—bone cancer	0.000998	0.00776	CcSEcCtD
Theophylline—Extravasation—Methotrexate—bone cancer	0.000986	0.00767	CcSEcCtD
Theophylline—Hyperuricaemia—Methotrexate—bone cancer	0.000928	0.00722	CcSEcCtD
Theophylline—Extravasation—Epirubicin—bone cancer	0.000923	0.00718	CcSEcCtD
Theophylline—Ventricular extrasystoles—Epirubicin—bone cancer	0.000892	0.00694	CcSEcCtD
Theophylline—Blood uric acid increased—Methotrexate—bone cancer	0.000876	0.00682	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—bone cancer	0.000868	0.00675	CcSEcCtD
Theophylline—Caffeine—CYP3A4—bone cancer	0.000867	0.255	CrCbGaD
Theophylline—Extravasation—Doxorubicin—bone cancer	0.000854	0.00664	CcSEcCtD
Theophylline—Ventricular extrasystoles—Doxorubicin—bone cancer	0.000825	0.00642	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—bone cancer	0.00082	0.00638	CcSEcCtD
Theophylline—Hyperuricaemia—Doxorubicin—bone cancer	0.000803	0.00625	CcSEcCtD
Theophylline—Dermatitis contact—Epirubicin—bone cancer	0.000796	0.00619	CcSEcCtD
Theophylline—Coma—Methotrexate—bone cancer	0.000786	0.00612	CcSEcCtD
Theophylline—Blood uric acid increased—Doxorubicin—bone cancer	0.000759	0.0059	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—bone cancer	0.000737	0.00573	CcSEcCtD
Theophylline—Coma—Epirubicin—bone cancer	0.000736	0.00572	CcSEcCtD
Theophylline—Flushing—Cisplatin—bone cancer	0.000731	0.00569	CcSEcCtD
Theophylline—Polyuria—Methotrexate—bone cancer	0.000712	0.00553	CcSEcCtD
Theophylline—Arrhythmia—Cisplatin—bone cancer	0.000704	0.00547	CcSEcCtD
Theophylline—Alopecia—Cisplatin—bone cancer	0.000696	0.00541	CcSEcCtD
Theophylline—Coma—Doxorubicin—bone cancer	0.000681	0.0053	CcSEcCtD
Theophylline—Phlebitis—Epirubicin—bone cancer	0.000679	0.00528	CcSEcCtD
Theophylline—Dermatitis exfoliative—Methotrexate—bone cancer	0.000662	0.00515	CcSEcCtD
Theophylline—Anaphylactoid reaction—Methotrexate—bone cancer	0.000646	0.00502	CcSEcCtD
Theophylline—Tremor—Cisplatin—bone cancer	0.000642	0.005	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—bone cancer	0.000628	0.00488	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—bone cancer	0.00062	0.00482	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—bone cancer	0.000604	0.0047	CcSEcCtD
Theophylline—Irritability—Methotrexate—bone cancer	0.000596	0.00464	CcSEcCtD
Theophylline—Convulsion—Cisplatin—bone cancer	0.000594	0.00462	CcSEcCtD
Theophylline—Anxiety—Cisplatin—bone cancer	0.000582	0.00452	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000573	0.00446	CcSEcCtD
Theophylline—Anaphylactic shock—Cisplatin—bone cancer	0.00056	0.00435	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000559	0.00435	CcSEcCtD
Theophylline—Infection—Cisplatin—bone cancer	0.000556	0.00432	CcSEcCtD
Theophylline—Nervous system disorder—Cisplatin—bone cancer	0.000549	0.00427	CcSEcCtD
Theophylline—Tachycardia—Cisplatin—bone cancer	0.000546	0.00425	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—bone cancer	0.000534	0.00415	CcSEcCtD
Theophylline—Anorexia—Cisplatin—bone cancer	0.000533	0.00415	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—bone cancer	0.000532	0.00414	CcSEcCtD
Theophylline—Hypotension—Cisplatin—bone cancer	0.000523	0.00407	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—bone cancer	0.000494	0.00384	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—bone cancer	0.000492	0.00383	CcSEcCtD
Theophylline—Decreased appetite—Cisplatin—bone cancer	0.000486	0.00378	CcSEcCtD
Theophylline—Haematuria—Methotrexate—bone cancer	0.000459	0.00357	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—bone cancer	0.000456	0.00355	CcSEcCtD
Theophylline—Body temperature increased—Cisplatin—bone cancer	0.000442	0.00344	CcSEcCtD
Theophylline—Haematuria—Epirubicin—bone cancer	0.00043	0.00334	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—bone cancer	0.000422	0.00328	CcSEcCtD
Theophylline—Hypersensitivity—Cisplatin—bone cancer	0.000412	0.00321	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—bone cancer	0.000398	0.00309	CcSEcCtD
Theophylline—Diarrhoea—Cisplatin—bone cancer	0.000383	0.00298	CcSEcCtD
Theophylline—Alopecia—Methotrexate—bone cancer	0.000382	0.00297	CcSEcCtD
Theophylline—Flushing—Epirubicin—bone cancer	0.000375	0.00292	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—bone cancer	0.000361	0.00281	CcSEcCtD
Theophylline—Alopecia—Epirubicin—bone cancer	0.000357	0.00278	CcSEcCtD
Theophylline—Vomiting—Cisplatin—bone cancer	0.000356	0.00277	CcSEcCtD
Theophylline—Rash—Cisplatin—bone cancer	0.000353	0.00274	CcSEcCtD
Theophylline—Dermatitis—Cisplatin—bone cancer	0.000353	0.00274	CcSEcCtD
Theophylline—Flushing—Doxorubicin—bone cancer	0.000347	0.0027	CcSEcCtD
Theophylline—Tension—Epirubicin—bone cancer	0.000346	0.00269	CcSEcCtD
Theophylline—Nervousness—Epirubicin—bone cancer	0.000342	0.00266	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—bone cancer	0.000334	0.0026	CcSEcCtD
Theophylline—Nausea—Cisplatin—bone cancer	0.000332	0.00259	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—bone cancer	0.000331	0.00257	CcSEcCtD
Theophylline—Convulsion—Methotrexate—bone cancer	0.000326	0.00254	CcSEcCtD
Theophylline—Agitation—Epirubicin—bone cancer	0.000324	0.00252	CcSEcCtD
Theophylline—Tension—Doxorubicin—bone cancer	0.00032	0.00249	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—bone cancer	0.000316	0.00246	CcSEcCtD
Theophylline—Palpitations—Epirubicin—bone cancer	0.000311	0.00242	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—bone cancer	0.000307	0.00239	CcSEcCtD
Theophylline—Convulsion—Epirubicin—bone cancer	0.000305	0.00237	CcSEcCtD
Theophylline—Infection—Methotrexate—bone cancer	0.000305	0.00237	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—bone cancer	0.000301	0.00234	CcSEcCtD
Theophylline—Agitation—Doxorubicin—bone cancer	0.000299	0.00233	CcSEcCtD
Theophylline—Anxiety—Epirubicin—bone cancer	0.000299	0.00232	CcSEcCtD
Theophylline—Anorexia—Methotrexate—bone cancer	0.000293	0.00228	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—bone cancer	0.000288	0.00224	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—bone cancer	0.000287	0.00224	CcSEcCtD
Theophylline—Hypotension—Methotrexate—bone cancer	0.000287	0.00223	CcSEcCtD
Theophylline—Infection—Epirubicin—bone cancer	0.000285	0.00222	CcSEcCtD
Theophylline—Shock—Epirubicin—bone cancer	0.000283	0.0022	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—bone cancer	0.000282	0.0022	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—bone cancer	0.000282	0.00219	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—bone cancer	0.00028	0.00218	CcSEcCtD
Theophylline—Insomnia—Methotrexate—bone cancer	0.000278	0.00216	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—bone cancer	0.000276	0.00215	CcSEcCtD
Theophylline—Anorexia—Epirubicin—bone cancer	0.000274	0.00213	CcSEcCtD
Theophylline—Hypotension—Epirubicin—bone cancer	0.000269	0.00209	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—bone cancer	0.000267	0.00208	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—bone cancer	0.000266	0.00207	CcSEcCtD
Theophylline—Infection—Doxorubicin—bone cancer	0.000264	0.00205	CcSEcCtD
Theophylline—Shock—Doxorubicin—bone cancer	0.000262	0.00203	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—bone cancer	0.000261	0.00203	CcSEcCtD
Theophylline—Insomnia—Epirubicin—bone cancer	0.00026	0.00202	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—bone cancer	0.00026	0.00202	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—bone cancer	0.000253	0.00197	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—bone cancer	0.000251	0.00195	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—bone cancer	0.00025	0.00194	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—bone cancer	0.000248	0.00193	CcSEcCtD
Theophylline—Urticaria—Methotrexate—bone cancer	0.000244	0.0019	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—bone cancer	0.000243	0.00189	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—bone cancer	0.000243	0.00189	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—bone cancer	0.00024	0.00187	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—bone cancer	0.000235	0.00183	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—bone cancer	0.000231	0.0018	CcSEcCtD
Theophylline—Urticaria—Epirubicin—bone cancer	0.000228	0.00178	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—bone cancer	0.000227	0.00177	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—bone cancer	0.000227	0.00177	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—bone cancer	0.000226	0.00176	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—bone cancer	0.000217	0.00169	CcSEcCtD
Theophylline—Pruritus—Methotrexate—bone cancer	0.000217	0.00169	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—bone cancer	0.000212	0.00165	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—bone cancer	0.000211	0.00164	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—bone cancer	0.00021	0.00163	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—bone cancer	0.00021	0.00163	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—bone cancer	0.00021	0.00163	CcSEcCtD
Theophylline—Pruritus—Epirubicin—bone cancer	0.000203	0.00158	CcSEcCtD
Theophylline—Dizziness—Methotrexate—bone cancer	0.000203	0.00158	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—bone cancer	0.000197	0.00153	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—bone cancer	0.000196	0.00152	CcSEcCtD
Theophylline—Vomiting—Methotrexate—bone cancer	0.000195	0.00152	CcSEcCtD
Theophylline—Rash—Methotrexate—bone cancer	0.000194	0.00151	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—bone cancer	0.000193	0.0015	CcSEcCtD
Theophylline—Headache—Methotrexate—bone cancer	0.000192	0.0015	CcSEcCtD
Theophylline—Dizziness—Epirubicin—bone cancer	0.00019	0.00148	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—bone cancer	0.000188	0.00146	CcSEcCtD
Theophylline—Vomiting—Epirubicin—bone cancer	0.000183	0.00142	CcSEcCtD
Theophylline—Nausea—Methotrexate—bone cancer	0.000182	0.00142	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—bone cancer	0.000182	0.00142	CcSEcCtD
Theophylline—Rash—Epirubicin—bone cancer	0.000181	0.00141	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—bone cancer	0.000181	0.00141	CcSEcCtD
Theophylline—Headache—Epirubicin—bone cancer	0.00018	0.0014	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—bone cancer	0.000176	0.00137	CcSEcCtD
Theophylline—Nausea—Epirubicin—bone cancer	0.000171	0.00133	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—bone cancer	0.000169	0.00131	CcSEcCtD
Theophylline—Rash—Doxorubicin—bone cancer	0.000168	0.0013	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—bone cancer	0.000167	0.0013	CcSEcCtD
Theophylline—Headache—Doxorubicin—bone cancer	0.000167	0.0013	CcSEcCtD
Theophylline—Nausea—Doxorubicin—bone cancer	0.000158	0.00123	CcSEcCtD
Theophylline—HDAC2—Gene Expression—EIF2S1—bone cancer	9.25e-05	0.00055	CbGpPWpGaD
Theophylline—ADA—Metabolism—CYP3A4—bone cancer	9.21e-05	0.000547	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—PLAU—bone cancer	9.21e-05	0.000547	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—GNA11—bone cancer	9.1e-05	0.000541	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—SMO—bone cancer	9.03e-05	0.000537	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—SMO—bone cancer	8.91e-05	0.000529	CbGpPWpGaD
Theophylline—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.75e-05	0.00052	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—GRM4—bone cancer	8.73e-05	0.000519	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—RGS1—bone cancer	8.73e-05	0.000519	CbGpPWpGaD
Theophylline—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.67e-05	0.000515	CbGpPWpGaD
Theophylline—HDAC2—Disease—ENO2—bone cancer	8.64e-05	0.000514	CbGpPWpGaD
Theophylline—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.59e-05	0.000511	CbGpPWpGaD
Theophylline—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.59e-05	0.00051	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NDUFA12—bone cancer	8.56e-05	0.000509	CbGpPWpGaD
Theophylline—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.55e-05	0.000508	CbGpPWpGaD
Theophylline—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.48e-05	0.000504	CbGpPWpGaD
Theophylline—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	8.47e-05	0.000503	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	8.41e-05	0.0005	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—GNA11—bone cancer	8.26e-05	0.000491	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—IL3—bone cancer	8.25e-05	0.00049	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—GRM1—bone cancer	8.15e-05	0.000484	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—GNA11—bone cancer	8.15e-05	0.000484	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—SMO—bone cancer	8.13e-05	0.000483	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NDUFA12—bone cancer	8.07e-05	0.00048	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—EZH2—bone cancer	8.04e-05	0.000478	CbGpPWpGaD
Theophylline—HDAC2—Disease—DHFR—bone cancer	8.02e-05	0.000477	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—SMO—bone cancer	7.88e-05	0.000468	CbGpPWpGaD
Theophylline—ADA—Metabolism—GSTP1—bone cancer	7.88e-05	0.000468	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—TP53—bone cancer	7.86e-05	0.000467	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—SMO—bone cancer	7.75e-05	0.000461	CbGpPWpGaD
Theophylline—HDAC2—Circadian rythm related genes—TP53—bone cancer	7.75e-05	0.00046	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.75e-05	0.00046	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.75e-05	0.00046	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—ATF1—bone cancer	7.57e-05	0.00045	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—GRM1—bone cancer	7.57e-05	0.00045	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL3—bone cancer	7.49e-05	0.000445	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—GNA11—bone cancer	7.43e-05	0.000442	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NDUFA12—bone cancer	7.4e-05	0.00044	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL3—bone cancer	7.38e-05	0.000439	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—SMO—bone cancer	7.38e-05	0.000439	CbGpPWpGaD
Theophylline—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.34e-05	0.000436	CbGpPWpGaD
Theophylline—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	7.24e-05	0.00043	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—GNA11—bone cancer	7.21e-05	0.000428	CbGpPWpGaD
Theophylline—ADORA2A—Circadian rythm related genes—TP53—bone cancer	7.2e-05	0.000428	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SMO—bone cancer	7.18e-05	0.000427	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NT5C3A—bone cancer	7.09e-05	0.000422	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—GNA11—bone cancer	7.09e-05	0.000421	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—EGFR—bone cancer	6.96e-05	0.000414	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—ATF1—bone cancer	6.91e-05	0.000411	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SMO—bone cancer	6.91e-05	0.000411	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SMO—bone cancer	6.83e-05	0.000406	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—GNA11—bone cancer	6.75e-05	0.000401	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL3—bone cancer	6.74e-05	0.000401	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—ATF1—bone cancer	6.7e-05	0.000398	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NT5C3A—bone cancer	6.69e-05	0.000398	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—ATF1—bone cancer	6.59e-05	0.000392	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—GNA11—bone cancer	6.57e-05	0.00039	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL3—bone cancer	6.54e-05	0.000388	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—EGFR—bone cancer	6.47e-05	0.000385	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL3—bone cancer	6.43e-05	0.000382	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—GNA11—bone cancer	6.32e-05	0.000376	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TGFBR2—bone cancer	6.32e-05	0.000375	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—ATF1—bone cancer	6.27e-05	0.000373	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—GNA11—bone cancer	6.24e-05	0.000371	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NT5C3A—bone cancer	6.13e-05	0.000364	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL3—bone cancer	6.12e-05	0.000364	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—ATF1—bone cancer	6.1e-05	0.000363	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NDUFA12—bone cancer	6.08e-05	0.000361	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NDUFA12—bone cancer	6.02e-05	0.000358	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL3—bone cancer	5.95e-05	0.000354	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IGF1R—bone cancer	5.94e-05	0.000353	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—ATF1—bone cancer	5.88e-05	0.000349	CbGpPWpGaD
Theophylline—HDAC2—Disease—TGFBR2—bone cancer	5.81e-05	0.000345	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—ATF1—bone cancer	5.81e-05	0.000345	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TGFBR2—bone cancer	5.76e-05	0.000343	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SMO—bone cancer	5.74e-05	0.000341	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL3—bone cancer	5.73e-05	0.000341	CbGpPWpGaD
Theophylline—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.67e-05	0.000337	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL3—bone cancer	5.66e-05	0.000337	CbGpPWpGaD
Theophylline—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.59e-05	0.000332	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TGFBR2—bone cancer	5.59e-05	0.000332	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TGFBR2—bone cancer	5.5e-05	0.000327	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IGF1R—bone cancer	5.42e-05	0.000322	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SMO—bone cancer	5.34e-05	0.000317	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IGF1R—bone cancer	5.26e-05	0.000313	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—GNA11—bone cancer	5.25e-05	0.000312	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TGFBR2—bone cancer	5.23e-05	0.000311	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IGF1R—bone cancer	5.17e-05	0.000307	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NDUFA12—bone cancer	5.15e-05	0.000306	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TGFBR2—bone cancer	5.09e-05	0.000303	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—TP53—bone cancer	5.08e-05	0.000302	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NT5C3A—bone cancer	5.03e-05	0.000299	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NT5C3A—bone cancer	4.99e-05	0.000297	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IGF1R—bone cancer	4.92e-05	0.000293	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFBR2—bone cancer	4.9e-05	0.000291	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—ATF1—bone cancer	4.88e-05	0.00029	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—GNA11—bone cancer	4.88e-05	0.00029	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFBR2—bone cancer	4.84e-05	0.000288	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IGF1R—bone cancer	4.79e-05	0.000285	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL3—bone cancer	4.76e-05	0.000283	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ENO2—bone cancer	4.76e-05	0.000283	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—TP53—bone cancer	4.63e-05	0.000275	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IGF1R—bone cancer	4.61e-05	0.000274	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IGF1R—bone cancer	4.56e-05	0.000271	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—ATF1—bone cancer	4.54e-05	0.00027	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL3—bone cancer	4.42e-05	0.000263	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—DHFR—bone cancer	4.41e-05	0.000262	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KIT—bone cancer	4.31e-05	0.000256	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NT5C3A—bone cancer	4.26e-05	0.000253	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—GNA11—bone cancer	4.12e-05	0.000245	CbGpPWpGaD
Theophylline—ADA—Metabolism—PTGS2—bone cancer	4.08e-05	0.000243	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFBR2—bone cancer	4.07e-05	0.000242	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—BRAF—bone cancer	4.05e-05	0.000241	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NDUFA12—bone cancer	3.97e-05	0.000236	CbGpPWpGaD
Theophylline—HDAC2—Disease—KIT—bone cancer	3.97e-05	0.000236	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KIT—bone cancer	3.93e-05	0.000234	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—EGFR—bone cancer	3.93e-05	0.000233	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IGF1R—bone cancer	3.83e-05	0.000228	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KIT—bone cancer	3.81e-05	0.000227	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFBR2—bone cancer	3.78e-05	0.000225	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KIT—bone cancer	3.75e-05	0.000223	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—CYP3A4—bone cancer	3.74e-05	0.000222	CbGpPWpGaD
Theophylline—HDAC2—Disease—BRAF—bone cancer	3.73e-05	0.000222	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.72e-05	0.000221	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TP53—bone cancer	3.7e-05	0.00022	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—BRAF—bone cancer	3.7e-05	0.00022	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—BRAF—bone cancer	3.58e-05	0.000213	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—EGFR—bone cancer	3.58e-05	0.000213	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KIT—bone cancer	3.57e-05	0.000212	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IGF1R—bone cancer	3.56e-05	0.000212	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—BRAF—bone cancer	3.53e-05	0.00021	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—EGFR—bone cancer	3.47e-05	0.000207	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KIT—bone cancer	3.47e-05	0.000206	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—EGFR—bone cancer	3.42e-05	0.000203	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MDM2—bone cancer	3.39e-05	0.000202	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—BRAF—bone cancer	3.36e-05	0.000199	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KIT—bone cancer	3.34e-05	0.000199	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KIT—bone cancer	3.3e-05	0.000196	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NT5C3A—bone cancer	3.29e-05	0.000196	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—BRAF—bone cancer	3.27e-05	0.000194	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—EGFR—bone cancer	3.25e-05	0.000193	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—GSTP1—bone cancer	3.2e-05	0.00019	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—EGFR—bone cancer	3.16e-05	0.000188	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—BRAF—bone cancer	3.14e-05	0.000187	CbGpPWpGaD
Theophylline—HDAC2—Disease—MDM2—bone cancer	3.12e-05	0.000186	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ENO2—bone cancer	3.11e-05	0.000185	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—BRAF—bone cancer	3.11e-05	0.000185	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MDM2—bone cancer	3.1e-05	0.000184	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—EGFR—bone cancer	3.05e-05	0.000181	CbGpPWpGaD
Theophylline—HDAC2—Disease—PTGS2—bone cancer	3.01e-05	0.000179	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—EGFR—bone cancer	3.01e-05	0.000179	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MDM2—bone cancer	3e-05	0.000179	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MDM2—bone cancer	2.95e-05	0.000176	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—JUN—bone cancer	2.95e-05	0.000175	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ENO2—bone cancer	2.93e-05	0.000174	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—DHFR—bone cancer	2.88e-05	0.000171	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MMP9—bone cancer	2.87e-05	0.000171	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MDM2—bone cancer	2.81e-05	0.000167	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KIT—bone cancer	2.78e-05	0.000165	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MDM2—bone cancer	2.74e-05	0.000163	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—DHFR—bone cancer	2.72e-05	0.000162	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GNA11—bone cancer	2.69e-05	0.00016	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—JUN—bone cancer	2.69e-05	0.00016	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ENO2—bone cancer	2.69e-05	0.00016	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MDM2—bone cancer	2.63e-05	0.000157	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MMP9—bone cancer	2.62e-05	0.000156	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—JUN—bone cancer	2.61e-05	0.000155	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—BRAF—bone cancer	2.61e-05	0.000155	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MDM2—bone cancer	2.6e-05	0.000155	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KIT—bone cancer	2.58e-05	0.000153	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—JUN—bone cancer	2.57e-05	0.000153	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MMP9—bone cancer	2.54e-05	0.000151	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GNA11—bone cancer	2.54e-05	0.000151	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MMP9—bone cancer	2.5e-05	0.000149	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—DHFR—bone cancer	2.49e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—JUN—bone cancer	2.44e-05	0.000145	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CYP3A4—bone cancer	2.44e-05	0.000145	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—BRAF—bone cancer	2.43e-05	0.000144	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MMP9—bone cancer	2.38e-05	0.000141	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—JUN—bone cancer	2.38e-05	0.000141	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—EGFR—bone cancer	2.35e-05	0.00014	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GNA11—bone cancer	2.33e-05	0.000138	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—EGFR—bone cancer	2.32e-05	0.000138	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MMP9—bone cancer	2.31e-05	0.000138	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CYP3A4—bone cancer	2.3e-05	0.000137	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.29e-05	0.000136	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—JUN—bone cancer	2.29e-05	0.000136	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—JUN—bone cancer	2.26e-05	0.000134	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MMP9—bone cancer	2.23e-05	0.000132	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ENO2—bone cancer	2.2e-05	0.000131	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MMP9—bone cancer	2.2e-05	0.000131	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MDM2—bone cancer	2.19e-05	0.00013	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ENO2—bone cancer	2.19e-05	0.00013	CbGpPWpGaD
Theophylline—HDAC2—Disease—EGFR—bone cancer	2.13e-05	0.000127	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—EGFR—bone cancer	2.12e-05	0.000126	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP3A4—bone cancer	2.11e-05	0.000125	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.1e-05	0.000125	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GSTP1—bone cancer	2.09e-05	0.000124	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EGFR—bone cancer	2.05e-05	0.000122	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—DHFR—bone cancer	2.05e-05	0.000122	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MDM2—bone cancer	2.03e-05	0.000121	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—DHFR—bone cancer	2.03e-05	0.000121	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EGFR—bone cancer	2.02e-05	0.00012	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTP1—bone cancer	1.97e-05	0.000117	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—bone cancer	1.95e-05	0.000116	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EGFR—bone cancer	1.92e-05	0.000114	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GNA11—bone cancer	1.91e-05	0.000114	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—JUN—bone cancer	1.9e-05	0.000113	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GNA11—bone cancer	1.9e-05	0.000113	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EGFR—bone cancer	1.87e-05	0.000111	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO2—bone cancer	1.87e-05	0.000111	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—bone cancer	1.85e-05	0.00011	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTP1—bone cancer	1.81e-05	0.000107	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—bone cancer	1.8e-05	0.000107	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—bone cancer	1.78e-05	0.000106	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—bone cancer	1.78e-05	0.000106	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—JUN—bone cancer	1.77e-05	0.000105	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP3A4—bone cancer	1.73e-05	0.000103	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—DHFR—bone cancer	1.73e-05	0.000103	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—bone cancer	1.72e-05	0.000102	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—bone cancer	1.72e-05	0.000102	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP3A4—bone cancer	1.72e-05	0.000102	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.71e-05	0.000102	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—bone cancer	1.7e-05	0.000101	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—bone cancer	1.66e-05	9.85e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GNA11—bone cancer	1.62e-05	9.63e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—bone cancer	1.61e-05	9.59e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—bone cancer	1.57e-05	9.33e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—bone cancer	1.51e-05	8.98e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—bone cancer	1.49e-05	8.88e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—bone cancer	1.49e-05	8.87e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—bone cancer	1.48e-05	8.81e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—bone cancer	1.47e-05	8.73e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP3A4—bone cancer	1.47e-05	8.73e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.46e-05	8.68e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—bone cancer	1.44e-05	8.57e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—bone cancer	1.39e-05	8.26e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—DHFR—bone cancer	1.34e-05	7.95e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—bone cancer	1.26e-05	7.46e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—bone cancer	1.25e-05	7.46e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GNA11—bone cancer	1.25e-05	7.43e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—bone cancer	1.17e-05	6.93e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—bone cancer	1.08e-05	6.43e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—bone cancer	1.02e-05	6.06e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—bone cancer	9.69e-06	5.76e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—bone cancer	9.35e-06	5.56e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—bone cancer	7.68e-06	4.56e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—bone cancer	7.61e-06	4.53e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—bone cancer	6.51e-06	3.87e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—bone cancer	5.02e-06	2.98e-05	CbGpPWpGaD
